Zennova Pharmaceutical partners with Innogenix Pharmaceuticals


Zennova Pharma recently announced a partnership with Innogenix, a leading pharmaceutical company d in the United States. The collaboration grants Zennova varies of rights to access ten cutting-edge Rx products developed & under-developing by Innogenix, including the exclusive sales & marketing rights in greater China regions. This partnership also invites Zennova becoming a part of Innogenix Corporation's global supply chain, utilizing Zennova’s State-of-The-Art manufacturing facility in Chengdu, China.  The products covered under this agreement focus on critical healthcare areas such as sleep disorders and cardiovascular diseases, addressing vital gaps in medicines in both China and international markets.


This strategic partnership is an important milestone for Zennova Pharmaceuticals. In today's global landscape, collaborations between international pharmaceutical businesses have surged due to the industry's dynamic expansion and enhanced global market accessibility. As a result, focusing on both domestic and global pharmaceutical markets has become a widespread strategy to enhance international capabilities and overall competitiveness for growth.


About Innogenix

Located on Long Island, USA, Innogenix is an emerging specialty pharmaceutical company that identifies, develops, manufactures and markets complex and difficult-to-manufacture specialty and generic preion pharmaceutical products.

About Zennova Pharma

Zennova Pharma Group is a Cayman registered global pharmaceutical company.  Zennova company has R&D and manufacturing facilities in New York, New Jersey, and Chengdu, China. Its 350,000 sqf State-Of-The Art Pharmaceutical manufacturing facility is designed to qualify US FDA, EU EMA and China cGMP standards.  Zennova’s innovative world-leading LiquPaulsR technology platform enhances drug development and formulating. It has leading products under development in Ophthalmic, virology, oncology areas.

Revolve around its core values "Innovation for Better Medicine", the company aims to excel in both FDA-compliant innovative product development and high-quality product manufacturing, contributing to the global markets.